期刊文章JMIR出版物以患者为中心的移动医疗系统支持哮喘自我管理(呼吸卡塔尔世界杯8强波胆分析);设计、开发与利用%A Morita,Plinio Pelegrini %A Yeung,Melanie S %A Ferrone,Madonna %A Taite,Ann K %A Madeley,Carole %A Stevens Lavigne,Andrea %A To,Teresa %A Lougheed,M Diane %A Gupta,Samir %A Day,Andrew G %A Cafazzo,Joseph A %A Licskai,Christopher %+滑铁卢大学应用健康科学学院公共卫生与卫生系统学院，安大略省滑铁卢大学大学大道西200号，N2L 3G1，加拿大，15198884567 ext 31372，plinio.morita@uwaterloo.ca %K智能手机%K哮喘%K自我报告%K自我管理%K患者依从性%K远程医疗%K降低风险行为%K互联网%K监测，生理%K移动应用%D 2019 %7 28.01.2019 %9原文%J JMIR移动健康Uhealth %G英语%X背景:哮喘失控会对个人和健康系统产生重大负面影响。包括智能手机在内的基于网络的技术是实现循证护理和改善患者预后的新手段。目的:本研究的目的是设计、开发和评估哮喘协同自我管理(CSM)平台(呼吸)的使用情况，该平台使用基于国际循证临床指南的内容。方法:我们采用以用户为中心的设计方法和国际标准化组织认证的质量开发流程，设计并开发了基于web的移动健康(mHealth)平台，可在智能手机、平板电脑或台式机上访问。此外，breathe被设想为一个多功能的CSM移动健康平台，其内容基于国际临床实践指南，并符合国家隐私和安全规范。该系统通过(1)哮喘控制评估、(2)实时获取动态哮喘行动计划、(3)获取实时环境条件和(4)降低风险信息，实现了CSM(患者、提供者和呼吸)和哮喘患者的自我监测。数据收集方案收集了12个月的用户数据，在基线、6个月和12个月时进行了临床访问。使用结果包括用户与平台的交互、用户印象、自我报告的药物使用、哮喘症状概况、报告的峰值流量测量以及电子邮件提醒的传递和影响。 Results: We enrolled 138 patients with a mean age of 45.3 years to receive the breathe intervention. Majority were female (100/138, 72.5%), had a smartphone (92/138, 66.7%), and had a mean Asthma Control Test score of 18.3 (SD 4.9). A majority reported that breathe helped in the management of their asthma. Moreover, breathe scored 71.1 (SD 18.9) on the System Usability Scale. Overall, 123 patients had complete usage analytics datasets. The platform sent 7.96 reminder emails per patient per week (pppw), patients accessed breathe 3.08 times, journaled symptoms 2.56 times, reported medication usage 0.30 times, and reported peak flow measurements 0.92 times pppw. Furthermore, breathe calculated patients’ action plan zone of control 2.72 times pppw, with patients being in the green (well-controlled) zone in 47.71% (8300/17,396) of the total calculations. Usage analysis showed that 67.5% (83/123) of the participants used the app at week 4 and only 57.7% (71/123) by week 45. Physician visits, email reminders, and aged 50 years and above were associated with higher utilization. Conclusions: Individuals with asthma reported good usability and high satisfaction levels, reacted to breathe notifications, and had confidence in the platform’s assessment of asthma control. Strong utilization was seen at the intervention’s initiation, followed by a rapid reduction in use. Patient reminders, physician visits, and being aged 50 years and above were associated with higher utilization. Trial Registration: ClinicalTrials.gov NCT01964469; https://clinicaltrials.gov/ct2/show/NCT01964469 %M 30688654 %R 10.2196/10956 %U http://mhealth.www.mybigtv.com/2019/1/e10956/ %U https://doi.org/10.2196/10956 %U http://www.ncbi.nlm.nih.gov/pubmed/30688654